Elutia (ELUT) Revenue Growth (1y) (2020 - 2026)
Elutia (ELUT) Revenue Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.88 Bn | 176.59 Bn | 6.27 Bn | 7.78% |
| 2 | Stryker | 128.94 Bn | 126.06 Bn | 3.81 Bn | 2.63% |
| 3 | Medtronic | 108.75 Bn | 99.53 Bn | 6.41 Bn | 9.86% |
| 4 | Boston Scientific | 68.65 Bn | 67.19 Bn | 3.61 Bn | 11.58% |
| 5 | Edwards Lifesciences | 48.22 Bn | 44.55 Bn | 1.29 Bn | 16.70% |
| 6 | Dexcom | 28.43 Bn | 27.31 Bn | 750.30 Mn | 15.05% |
| 7 | GE HealthCare Technologies | 28.32 Bn | 26.03 Bn | 1.98 Bn | 7.41% |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 25.10 Bn | 21.98 Bn | 2.07 Bn | 6.08% |
| 10 | Elutia | 40.03 Mn | 11.54 Mn | 1.80 Mn | 5.52% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.52% |
| Dec 31, 2025 | 16.16% |
| Sep 30, 2025 | -9.26% |
| Jun 30, 2025 | -0.45% |
| Mar 31, 2025 | -55.92% |
| Dec 31, 2024 | -52.07% |
| Sep 30, 2024 | -40.23% |
| Jun 30, 2024 | -0.94% |
| Mar 31, 2024 | 4.72% |
| Dec 31, 2023 | -10.81% |
| Sep 30, 2023 | 4.75% |
| Jun 30, 2023 | -49.75% |
| Mar 31, 2023 | -44.39% |
| Dec 31, 2022 | -39.35% |
| Sep 30, 2022 | -49.07% |
| Jun 30, 2022 | 3.93% |
| Mar 31, 2022 | -10.78% |
| Dec 31, 2021 | -12.88% |
| Sep 30, 2021 | -2.45% |
| Jun 30, 2021 | 41.74% |